Browse the full Event Guide to discover:
16+ expert speakers across gene therapy biopharma, including process development leaders from Amgen, Astellas Gene Therapies, Janssen, Meria GTx, REGENXBIO, Ultragenyx and more!
Deep-dive workshop where you will
re-evaluate their approach to upstream design by developing strategies to look forward to commercialisation & manufacturing prior to R&D & Upstream Development
6+ hours of dedicated networking time across
speed-networking, discussions and refreshment breaks to strengthen and form long-term mutually beneficial relationships
Case studies from Astella Gene Therapies, Ultragenyx and REGENXBIO on improving upstream and downstream processes and cell line development
Presentation from regulatory experts to help unpick the July 2023 FDA Draft Guidance on Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
Companies on the Program:
